JAMJOOM PHARMA - Latest News
Osool & Bakheet issues Q1 2024 earnings forecast
Argaam 20/04/2024
Highest-paid executives, board members of Saudi-listed firms in 2023
Argaam Special 16/04/2024
GIB Capital previews Q1 2024 earnings
Argaam 14/04/2024
Al Rajhi Capital issues Q1 profit forecasts for TASI-listed firms
Argaam 06/04/2024
Jamjoom Pharma board proposes 15% dividend for H2 2023
Argaam 04/04/2024
Jamjoom Pharma's 2023 net profit exceeds estimates: United Securities
Argaam 27/03/2024
Jamjoom Pharma expects up to 15% revenue growth over next 2 years, plans expansion
Argaam 25/03/2024
Jamjoom Pharma to disclose 2023 financials on March 25
Argaam 19/03/2024
Jamjoom Pharma seen to post profit growth in Q4 2023
Argaam Special 20/02/2024
Jamjoom Pharma signs contract with LCGPA to localize drug production
Argaam 30/01/2024
LCGPA signs 4 agreements to localize pharma industry
Argaam 29/01/2024
Jamjoom Pharma provides SAR 17.7M corporate guarantee to Algeria JV
Argaam 21/01/2024
GIB Capital previews Q4 2023 earnings
Argaam Special 10/01/2024
Jamjoom Pharma to participate in 42nd JP Morgan Healthcare Conference
Argaam 10/01/2024
How did analysts view TASI performance, top picks for 2024?
Argaam Special 09/01/2024
Al Rajhi Capital issues Q4 2023 earnings forecasts
Argaam Special 08/01/2024
United Securities previews Q4 2023 earnings for Saudi firms
Argaam Special 07/01/2024
Al Rajhi Capital expects TASI to hit 12,647 pts, names top picks
Argaam 07/01/2024
Trading ban on Jamjoom Pharma’s major shareholders ends today
Argaam 19/12/2023
How did analysts view Jamjoom Pharma’s Q3 financials?
Argaam Special 05/12/2023
GIB Capital sets rating for Jamjoom Pharma
Argaam 03/12/2023
Al Rajhi Capital says Saudi pharmaceuticals sector poised for growth; sets recommendations, TP
Argaam 23/11/2023
Jamjoom Pharma offers SAR 18.5M corporate guarantee for Algeria JV
Argaam 22/11/2023
MSCI adds 1 fund, 2 firms to Small Cap Index
Argaam 15/11/2023
Jamjoom Pharma to disclose 9M 2023 results on Nov. 7
Argaam 01/11/2023
Al Rajhi Capital issues Q3 profit forecasts for Saudi-listed companies
Argaam Special 05/10/2023
TASI leaps 5.5% in 9M 2023; Etihad Atheeb, Elm top gainers
ِArgaam special 30/09/2023
Tadawul announces indices maintenance for Q3 2023
Argaam 25/09/2023
Jamjoom Pharma revises up 2023 guidance
Argaam Special 10/08/2023
Jamjoom Pharma board OKs 10% dividend for H1 2023
ِArgaam 10/08/2023
Jamjoom Pharma to raise capital of its Algeria joint venture
Argaam 31/07/2023
Jamjoom Pharma targets 17% revenue growth, higher profit margin in 2023: CEO
Argaam Special 11/07/2023
Al Rajhi Capital issues Q2 earnings estimates
ِArgaam 10/07/2023
Al Rajhi Capital begins coverage of Saudi pharma sector, assigns ratings
Argaam 05/07/2023
GIB Capital initiates coverage on Jamjoom Pharma
ِArgaam 20/06/2023
Jamjoom Pharma to debut on Tadawul today
Argaam Special 20/06/2023
Jamjoom Pharma shares to debut on Tadawul on June 20
Argaam 18/06/2023
Edaa deposits Jamjoom Pharma securities into shareholder accounts
Argaam 15/06/2023
Jamjoom Pharma retail IPO 11x covered, 4 shares allotted per subscriber
Argaam 06/06/2023
Retail subscription to 2.1 mln shares of Jamjoom Pharma IPO starts today
Argaam Special 30/05/2023
Jamjoom Pharma IPO: subscription period, key dates
Argaam 30/05/2023
Here’s a list of receiving banks for Jamjoon Pharma IPO
Argaam 30/05/2023
Jamjoom Pharma sets IPO final price at SAR 60/share
Argaam 25/05/2023
Jamjoom Pharma sets IPO price range between 56-60/share
Argaam 15/05/2023
Jamjoom Pharma allocates 5.17 mln shares to cornerstone investors
Argaam 14/05/2023
Jamjoom Pharma issues prospectus to offer 21 mln shares on Tadawul
Argaam 04/05/2023
Jamjoom Pharma gets CMA nod to offer 21 mln shares on Tadawul
Argaam 28/12/2022